Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Irvine Pharmaceutical Services To Expand | Contract Pharma

What are you searching for?

Sign in
Breaking News

Irvine Pharmaceutical Services To Expand

Will double filling, formulation and development capacity

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Irvine Pharmaceutical Services has plans to significantly increase capacity over the course of this fiscal year that will double capacity for filling (both lyophilized and liquid), formulation, and biopharmaceutical development by 2Q14.   
 
As part of this initiative, the company incorporated its Avrio parenteral manufacturing facility into the Irvine brand in January. Irvine has since increased technical staff across most departments and plans to add an additional 40 employees during the next 12 months.
 
Dr. Assad J. Kazeminy, Irvine’s chief executive officer and founder, described the plans as “a three-prong initiative for aggressive yet stable growth, with more highly trained technical personnel, state-of-the-art instrumentation and increased capacity for formulation, biopharmaceuticals and raw material testing.”
 
“We have been building to this trajectory for the past five years,” Dr. Kazeminy said. “We are ‘just in time’ to meet the quickly expanding needs of the biopharmaceutical industry as it adjusts to an improving economy, mounting regulatory restrictions and faster-to-market demands.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics